金沙检测线路js95(中国)股份有限公司-Official website

You are about to leave Peijia Medical's official Chinese website.
You have just clicked on a link to another website. After clicking Continue, you may be taken to a website run by a third party. We are not responsible for the review and control of content outside Peijia Medical's official Chinese website, nor do we assume any responsibility for business transactions or matters conducted outside Peijia Medical's official Chinese website. The use of other websites is subject to the terms of use and privacy policies of those websites. Certain products or information found on other websites may not be approved for your region or country.
Cancel
Continue
Brief News on Innovation
Company News Brief News on Innovation
Brief News on Innovation
FIRST IMPLANTATION IN THE FIM CLINICAL TRIAL OF Sutra Hemi-valve TRANSCATHETER MITRAL VALVE REPAIR SYSTEM
2025.09.12
FIRST IMPLANTATION IN THE FIM CLINICAL TRIAL OF Sutra Hemi-valve TRANSCATHE···

This announcement is made by Peijia Medical Limited (the “Company”, together wit···
Peijia Medical’s Hydrophilic Coating Guidewire  Received Registration Approval
2025.08.04
Peijia Medical’s Hydrophilic Coating Guidewire Received Registration Appro···

On July 30, 2025, Peijia Medical independently developed hydrophilic coating gui···
FIRST PATIENT IMPLANT IN THE GLOBAL CLINICAL STUDYOF THE MonarQ TTVR® SYSTEM
2025.07.16
FIRST PATIENT IMPLANT IN THE GLOBAL CLINICAL STUDYOF THE MonarQ TTVR® SYSTE···

This announcement is made by Peijia Medical Limited (the “Company”, together wit···
Peijia Medical Showcased Innovative Portfolio  at Beijing Valves 2025
2025.07.09
Peijia Medical Showcased Innovative Portfolio at Beijing Valves 2025

From July 2 to 6, 2025, Peijia Medical made a remarkable appearance at Beijing V···
China’s Independently Developed TEER   GeminiOne Gained Further Evidence:  Comparative Hemodynamic and  Biomechanical Evaluation
2025.07.02
China’s Independently Developed TEER GeminiOne Gained Further Evidence: ···

In July 2025, Dr. Jianfeng Chen, leading the R&D team at Peijia Medical, c···
OCC 2025 One-Year Follow-Up Results from Pivotal Trial of TaurusNXT® Non-glutaraldehyde Crosslinked DrytissueTAVR System Released
2025.05.24
OCC 2025 One-Year Follow-Up Results from Pivotal Trial of TaurusNXT® Non-gl···

From May 29 to June 1, 2025, the 19th Oriental Congress of Cardiology (OCC 2025)···
EuroPCR 2025 One-Year Follow-Up Results from Pivotal Trial of TaurusTrioTM TAVR System Released
2025.05.24
EuroPCR 2025 One-Year Follow-Up Results from Pivotal Trial of TaurusTrioTM ···

Highlights: The pivotal clinical trial enrolled 116 symptomatic patients wi···
EuroPCR 2025 30-Day Follow-Up Results from Initial Feasibility Study of Highlife® TSMVR System Released
2025.05.23
EuroPCR 2025 30-Day Follow-Up Results from Initial Feasibility Study of Hig···

Highlights: 1. The reported results were derived from a single-center feasi···
EuroPCR 2025 One-Year Follow-Up Results from Pivotal Trial of GeminiOne® TEER System Released
2025.05.23
EuroPCR 2025 One-Year Follow-Up Results from Pivotal Trial of GeminiOne® TE···

Highlights: The pivotal trial enrolled 130 patients (including 10 roll-in p···
ONE-YEAR FOLLOW-UP RESULTS OF THE REGISTRATION  TRIAL OF TAURUSTRIO™ TAV SYSTEM PRESENTED AT CHINA  VALVE (HANGZHOU) 2025
2025.04.21
ONE-YEAR FOLLOW-UP RESULTS OF THE REGISTRATION TRIAL OF TAURUSTRIO™ TAV SY···

On April 18, 2025, at the China Valve (Hangzhou) 2025 conference, Prof. Yan Yunf···
REGISTRATION APPLICATION FOR TaurusTrio™ TAV  SYSTEM ACCEPTED BY THE NMPA
2025.04.15
REGISTRATION APPLICATION FOR TaurusTrio™ TAV SYSTEM ACCEPTED BY THE NMPA

On April 14, 2025, Peijia Medical announced that the NMPA has formally accepted ···
HighLife granted US FDA Breakthrough Device Designation for its TMVR solution
2025.04.08
HighLife granted US FDA Breakthrough Device Designation for its TMVR soluti···

We are thrilled to congratulate our incredible partner HighLife Medical on ···
Home < 12345··· > Last
Top
XML 地图